CONTACT-03: New Insights on Immunotherapy and Kidney Cancer Treatment

Katy Beckermann, MD, PhD, of Vanderbilt University Medical Center, and Pedro Barata, MD, of University Hospitals Seidman Cancer Center, discuss key insights from the CONTACT-03 trial in kidney cancer. They explore the trial’s goals and design and its significance in evaluating the use of immune checkpoint inhibitors, specifically PD-L1 inhibitors, for patients who have progressed on previous immunotherapy.

Advertisement

Latest News

Advertisement
Advertisement
Editorial Advisory Board

The Uromigos Live and Unplugged 2024

The Uromigos Live & Unplugged 2024

The Uromigos Live & Unplugged 2024 will take place September 27-29 in Nashville, Tennessee.

This meeting is the third annual in-person event hosted by Thomas Powles, MD, and Brian Rini, MD, FASCO, in partnership with Mashup Media, featuring expert panels and audience discussion around the latest data in genitourinary oncology and vision for the future.

Expert Interviews

Knowledge Hubs

Curated clinical content based on conditions, therapies, and technologies

Prostate Cancer
Prostate Cancer

The Uromigos

Podcasts hosted by Professors Thomas Powles, MD, and Brian Rini, MD

Conference Coverage

Live meeting highlights

Irbaz B. Riaz, MBBS, PhDSPCS 2024 | November 5, 2024
In part six of this roundtable series, the panelists finish their discussion by reviewing immunotherapy in prostate cancer.
View More
Irbaz B. Riaz, MBBS, PhDSPCS 2024 | November 5, 2024
In part five of this roundtable series, the panelists discuss radiopharmaceuticals in the overall landscape of mCRPC.
Irbaz B. Riaz, MBBS, PhDSPCS 2024 | November 5, 2024
In part four of this roundtable series, the panelists discuss CRPC and the typical patterns of presentation.
Irbaz B. Riaz, MBBS, PhDSPCS 2024 | November 5, 2024
Part three of this roundtable delves into genomic biomarkers and the use of doublet and triplet therapies for mHSPC.

Video Insights

Clinical discussions with experts in the field

Network Websites